vs
Side-by-side financial comparison of Community West Bancshares (CWBC) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $38.3M, roughly 1.5× Community West Bancshares). On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 11.6%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 36.0%).
Community West BancsharesCWBCEarnings & Financial Report
Community West Bancshares is a registered bank holding company headquartered in California. It wholly owns Community West Bank under the Bank Holding Company Act.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
CWBC vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.3M | $57.3M |
| Net Profit | — | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | 40.0% | -82.2% |
| Net Margin | — | -83.0% |
| Revenue YoY | 11.6% | 36.9% |
| Net Profit YoY | — | -9.6% |
| EPS (diluted) | $0.58 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.3M | $57.3M | ||
| Q3 25 | $37.9M | $51.3M | ||
| Q2 25 | $35.7M | $48.5M | ||
| Q1 25 | $34.8M | $32.7M | ||
| Q4 24 | $34.3M | $41.8M | ||
| Q3 24 | $31.3M | $33.3M | ||
| Q2 24 | $30.5M | $29.1M | ||
| Q1 24 | $20.7M | $26.0M |
| Q4 25 | — | $-47.5M | ||
| Q3 25 | $10.9M | $-52.9M | ||
| Q2 25 | $7.8M | $-46.6M | ||
| Q1 25 | $8.3M | $-49.5M | ||
| Q4 24 | — | $-43.3M | ||
| Q3 24 | $3.4M | $-43.6M | ||
| Q2 24 | $-6.3M | $-32.3M | ||
| Q1 24 | $3.7M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
| Q4 25 | 40.0% | -82.2% | ||
| Q3 25 | 39.8% | -102.6% | ||
| Q2 25 | 30.2% | -93.4% | ||
| Q1 25 | 32.7% | -143.7% | ||
| Q4 24 | 31.0% | -98.6% | ||
| Q3 24 | 13.3% | -132.0% | ||
| Q2 24 | -25.9% | -139.2% | ||
| Q1 24 | 23.2% | -538.7% |
| Q4 25 | — | -83.0% | ||
| Q3 25 | 28.7% | -103.1% | ||
| Q2 25 | 22.0% | -96.1% | ||
| Q1 25 | 23.8% | -151.4% | ||
| Q4 24 | — | -103.6% | ||
| Q3 24 | 10.8% | -131.2% | ||
| Q2 24 | -20.7% | -110.9% | ||
| Q1 24 | 17.8% | -544.4% |
| Q4 25 | $0.58 | $-0.73 | ||
| Q3 25 | $0.57 | $-0.82 | ||
| Q2 25 | $0.41 | $-0.75 | ||
| Q1 25 | $0.44 | $-0.81 | ||
| Q4 24 | $0.29 | $-0.71 | ||
| Q3 24 | $0.18 | $-0.73 | ||
| Q2 24 | $-0.33 | $-0.55 | ||
| Q1 24 | $0.31 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $119.0M | $388.9M |
| Total DebtLower is stronger | $69.5M | — |
| Stockholders' EquityBook value | $409.6M | $139.1M |
| Total Assets | $3.7B | $480.2M |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $119.0M | $388.9M | ||
| Q3 25 | $121.6M | $416.1M | ||
| Q2 25 | $134.4M | $291.0M | ||
| Q1 25 | $148.4M | $314.5M | ||
| Q4 24 | $120.4M | $320.6M | ||
| Q3 24 | $149.0M | $298.4M | ||
| Q2 24 | $109.7M | $319.1M | ||
| Q1 24 | $61.0M | $201.2M |
| Q4 25 | $69.5M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $69.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $409.6M | $139.1M | ||
| Q3 25 | $397.6M | $148.8M | ||
| Q2 25 | $380.0M | $-11.9M | ||
| Q1 25 | $372.2M | $18.9M | ||
| Q4 24 | $362.7M | $21.7M | ||
| Q3 24 | $363.5M | $11.2M | ||
| Q2 24 | $350.2M | $39.3M | ||
| Q1 24 | $211.7M | $61.6M |
| Q4 25 | $3.7B | $480.2M | ||
| Q3 25 | $3.6B | $506.9M | ||
| Q2 25 | $3.6B | $372.7M | ||
| Q1 25 | $3.6B | $386.7M | ||
| Q4 24 | $3.5B | $392.3M | ||
| Q3 24 | $3.5B | $363.6M | ||
| Q2 24 | $3.5B | $381.8M | ||
| Q1 24 | $2.4B | $258.7M |
| Q4 25 | 0.17× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.19× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $46.1M | $-25.4M |
| Free Cash FlowOCF − Capex | $43.6M | — |
| FCF MarginFCF / Revenue | 113.9% | — |
| Capex IntensityCapex / Revenue | 6.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $77.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $46.1M | $-25.4M | ||
| Q3 25 | $13.2M | $-26.6M | ||
| Q2 25 | $11.5M | $-23.3M | ||
| Q1 25 | $11.1M | $-40.4M | ||
| Q4 24 | $22.2M | $-18.8M | ||
| Q3 24 | $7.8M | $-25.2M | ||
| Q2 24 | $5.2M | $-29.1M | ||
| Q1 24 | $4.0M | $-40.7M |
| Q4 25 | $43.6M | — | ||
| Q3 25 | $12.8M | — | ||
| Q2 25 | $10.6M | — | ||
| Q1 25 | $10.8M | — | ||
| Q4 24 | $17.2M | — | ||
| Q3 24 | $5.2M | — | ||
| Q2 24 | $4.8M | — | ||
| Q1 24 | $3.6M | — |
| Q4 25 | 113.9% | — | ||
| Q3 25 | 33.7% | — | ||
| Q2 25 | 29.6% | — | ||
| Q1 25 | 30.9% | — | ||
| Q4 24 | 50.0% | — | ||
| Q3 24 | 16.7% | — | ||
| Q2 24 | 15.7% | — | ||
| Q1 24 | 17.3% | — |
| Q4 25 | 6.6% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 2.7% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 14.7% | — | ||
| Q3 24 | 8.1% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 2.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.21× | — | ||
| Q2 25 | 1.47× | — | ||
| Q1 25 | 1.33× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.29× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
